Lysosomal phospholipase A 2 : A novel player in host immunity to  Mycobacterium tuberculosis by Schneider, Bianca E. et al.
2394 Bianca E. Schneider et al. Eur. J. Immunol. 2014. 44: 2394–2404DOI: 10.1002/eji.201344383
Lysosomal phospholipase A2: A novel player in host
immunity to Mycobacterium tuberculosis
Bianca E. Schneider1,2, Jochen Behrends1, Kristine Hagens1,
Nadine Harmel1, James A. Shayman3 and Ulrich E. Schaible1,2,4
1 Department of Molecular Infection Biology, Cellular Microbiology, Research Center Borstel,
Borstel, Germany
2 Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases,
London School of Hygiene & Tropical Medicine, London, UK
3 Department of Internal Medicine, Nephrology Division, University of Michigan, Ann Arbor,
MI, USA
4 German Centre for Infection Research, TTU-TB, Borstel, Germany
Phospholipases catalyze the cleavage of membrane phospholipids into smaller
bioactive molecules. The lysosomal phospholipase A2 (LPLA2) is specifically expressed
in macrophages. LPLA2 gene deletion in mice causes lysosomal phospholipid accumula-
tion in tissue macrophages leading to phospholipidosis. This phenotype becomes most
prominent in alveolar macrophages where LPLA2 contributes to surfactant phospholipid
degradation. High expression of LPLA2 in alveolar macrophages prompted us to investi-
gate its role in host immunity against the respiratory pathogenMycobacterium tuberculosis,
the causative agent of tuberculosis. Here we report that adaptive immune responses
to M. tuberculosis were impaired in LPLA2 deficient mice. Upon aerosol infection with
M. tuberculosis, LPLA2 deficient mice showed enhanced mycobacterial counts but less
lung immunopathology and pulmonary inflammatory responses. Compromised T-cell
priming in the lymph nodes was associated with impaired pulmonary T-cell recruitment
and activation. Together with reduced Th1 type cytokine production, these results indi-
cate that LPLA2 is indispensable for the induction of adaptive T-cell immunity toM. tuber-
culosis. Taken together, we identified an unexpected and novel function of a lysosomal
phospholipid-degrading enzyme.
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Introduction
Phospholipases form a ubiquitous class of enzymes that cleave
membrane phospholipids into smaller bioactive molecules [1].
Enzymes of the phospholipase A2 (PLA2) family play multi-
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ple roles in lung infection and inflammation [2]. Apart from
being involved in the generation of bioactive lipids such as
eicosanoids, which are involved in inflammation by regulating
cytokine and chemokine responses, direct bactericidal activity due
to hydrolysis of bacterial-membrane phospholipids has also been
shown for secretory PLA2 (sPLA2) [2, 3]. Despite the essential
function of lysosomes for membrane degradation, which is a pri-
mary function of phagocytes, only a few responsible enzymes
were identified so far. The lysosomal phospholipase A2 (LPLA2),
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newly designated group XV PLA A2, is specifically expressed in
macrophages with predominance in alveolar macrophages where
it is of specific relevance for surfactant phospholipid degradation
[4]. LPLA2 is a broad specificity PLA2 that is characterized by the
presence of both PLA2 and transacylase activity [5]. Among the
main substrates of the LPLA2 are phosphatidylcholine (PC) and
phosphatidylethanolamine (PE), which account for 84 and 2%
of the surfactant lipid in mice, respectively [4]. LPLA2 knockout
mice develop a lysosomal storage disease, that is, phospholipi-
dosis, which becomes obvious by phospholipid accumulation in
lysosomes of alveolar macrophages and peritoneal macrophages
[6]. By 1 year of age, LPLA2 KO mice develop increased lung
surfactant phospholipid levels and splenomegaly. The LPLA2 KO
phenotype demonstrates an essential function of this enzyme in
phospholipid turnover and membrane homeostasis.
The causative agent of tuberculosis, Mycobacterium tuberculo-
sis, establishes infection in the lung by aerosol transmission from
infected people. With 1.7 million deaths and 8 million new cases
annually, tuberculosis continues to have a major impact on public
health worldwide (WHO). After entering the lung in small
aerosol droplets, M. tuberculosis is taken up by resident alveolar
macrophages, which provide the initial niche for the pathogen’s
survival and replication. Infected alveolar macrophages together
with interstitial DCs enter the lung parenchyma where they ini-
tiate a local inflammatory reaction [7]. At the same time, DCs
and probably other APCs transport M. tuberculosis to the draining
lymph node, where antigen-specific CD4+ and CD8+ T cells are
primed [8, 9].
The predominance of LPLA2 in alveolar macrophages together
with this cell’s function in immunity and as initial habitat for
M. tuberculosis prompted us to ask whether LPLA2 contributes to
host responses against this intracellular pathogen. Upon M. tuber-
culosis aerosol infection, we observed abolished T-cell priming in
mediastinal lymph nodes (mLNs) of LPLA2 KO mice, which was
associated with recruitment and activation of pulmonary T cells
and impaired proinflammatory mediator production compared
with WT mice. Antigen-specific CD4+ T cells from infected lungs
of LPLA2 deficient mice failed to secrete IFN-γ. Consequently,
Th1 cytokine responses were strongly reduced, and mycobacterial
tissue loads significantly increased in LPLA2 KO when compared
with WT mice. Our findings reveal an essential and novel role of
LPLA2 in bridging innate and adaptive immune functions during
M. tuberculosis infection.
Results
Control of M. tuberculosis infection is impaired in
LPLA2 deficient mice
After entering the airways, M. tuberculosis is taken up by resi-
dent alveolar macrophages, which provide the first line of defence
but also a niche for its survival and replication. LPLA2 is highly
expressed in alveolar macrophages [4], which prompted us to ana-
lyze the outcome of and host responses to M. tuberculosis infec-
tion in LPLA2 KO mice. Mycobacterial loads were significantly
increased in lungs of LPLA2 KO mice when compared with those
from C57BL/6WTmice (Fig. 1A), indicating amuch better growth
and survival of M. tuberculosis in the absence of LPLA2. Signifi-
cantly higher bacterial loads 6 months after infection showed that
this phenotype was not transient but sustained over time (Fig. 1A).
The difference in lung CFU between LPLA2 and WT mice became
even more pronounced after high-dose infection (600 CFU per
lung), recovering >1 log higher bacterial loads from LPLA2 defi-
cient than from WT lungs 48 days after infection (Fig. 1B). In line
with CFU data, higher loads of tubercle bacilli were detected by
acid-fast staining in LPLA2 KO lung sections when compared with
WT lungs (Fig. 1C and D).
Survival time of LPLA2 KO mice was shortened upon high-dose
M. tuberculosis infection compared with that of WT controls but
was only observed very late in the chronic phase of infection and
statistically not significant (Fig. 1E).
LPLA2 deficiency leads to reduced inflammation
during M. tuberculosis infection
Despite higher numbers of mycobacteria in LPLA2 KO mice,
histopathological examination of theM. tuberculosis infected lungs
revealed less cellular infiltrates affecting smaller tissue areas in
these mice when compared with WT ones (Fig. 2A). Consistent
with the histological observations, the total immune cell number
in the lung after infection was significantly lower in LPLA2
KO mice when compared with WT mice (Fig. 2B). Strikingly,
spleens of LPLA2 deficient mice were significantly smaller in size
than WT spleens upon M. tuberculosis infection, as reflected by
lower total cell numbers and organ weight and spleen-to-body
weight ratio (Fig. 2B–D). Importantly, LPLA2 deficient spleens
contained less mycobacteria than WT ones over the first 6 weeks
post aerosol infection with M. tuberculosis (Fig. 2E) indicating
limited dissemination of M. tuberculosis from the pulmonary
entry site to peripheral lymphoid organs in LPLA2 KO mice.
However, 43 days after infection, M. tuberculosis numbers in
LPLA2 KO spleens reached those in WT spleens (Fig. 2E), which
reveals LPLA2 KO spleens, just like the lungs, as a more favor-
able environment for mycobacterial growth when compared with
WT ones.
Antimicrobial activity of LPLA2 deficient macrophages
Higher mycobacterial loads in lungs of LPLA2 deficient mice
prompted us to analyze whether LPLA2 deficiency impairs the
antimicrobial effector functions of macrophages. A direct bacteri-
cidal effect of LPLA2 could be ruled out by the fact that purified
recombinant LPLA2 had only a minor effect on the viability of
mycobacteria in vitro, which was tested under different media
conditions, that is, Ringer solution and PBS (Fig. 3A and data not
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Figure 1. Control of Mycobacterium tuber-
culosis infection in LPLA2 KO mice. LPLA2
KO and WT B6 mice were infected by
aerosol with 60 (A), 600 (B and E), or 250
(C and D) M. tuberculosis H37Rv per lung.
(A–C) Mice were sacrificed after the indi-
cated time points upon aerosol infection
and serial dilutions of lung lysates were
plated for CFU determination. Symbols
and bars represent individual mice and
means, respectively. Each graph repre-
sents an individual experiment of one
(A, B and E) or two (C andD) performed. (D)
Acid-fast staining of lung sections 20 and
43 days post-infection (p.i.). Representa-
tive images from one mouse out of five
analyzed in (C) are shown. (E) Long-term
observation upon high-dose M. tubercu-
losis infection. n = 6 (WT) and n = 5
(LPLA2 KO). Statistical analysis was per-
formed using the Student’s t-test for bac-
terial numbers and the log-rank test for
survival (*p < 0.05; **p < 0.01; *** p < 0.001).
shown). Moreover,M. tuberculosis survived and replicated equally
well in both WT and LPLA2 KO macrophages (Fig. 3C). Notably,
IFN-γ activation rendered both WT and LPLA2 KO macrophages
similarly capable of restricting growth of intracellular M. tuber-
culosis (Fig. 3B) and to produce nitric oxide (NO2−) (Fig. 3C).
However, we found reduced levels of TNF-α to be secreted into the
supernatant by LPLA2 KO peritoneal macrophages 24 h after infec-
tion with M. tuberculosis (Fig. 3D), suggesting that macrophages
are not fully activated in the absence of LPLA2.
Impaired T-cell responses to M. tuberculosis in LPLA2
deficient lungs
Reduced cellular infiltrates in LPLA2 KO lungs uponM. tuberculosis
infection indicated impaired immune cell recruitment to the pul-
monary site of infection. This assumption was indeed corroborated
by FACS analyses revealing decreased proportions and numbers of
CD11bhiLy6G+ infiltrating monocytes in LPLA2 KO compared with
WT lungs (Fig. 4A). Moreover, we found significantly reduced
Figure 2. Inflammatory tissue responses in the absence of LPLA2. LPLA2 KO and WT B6 mice were infected by aerosol with 250 (A and E) or 150
(B–D) Mycobacterium tuberculosis H37Rv per lung. (A) Representative H&E stains of lung sections of LPLA2 KO or B6 WT mice 43 days p.i. (n = 5).
(B–D) Total cell numbers, spleen weight, and spleen to body weight ratios were determined from lungs and spleens of naı¨ve or M. tuberculosis
infected animals. (E) Serial dilutions of spleen lysates were plated for CFU determination. Symbols and bars represent individual mice and means,
respectively, and data from one experiment representative of two experiments are shown. Statistical analysis was performed using the Student’s
t-test (*p < 0.05; **p < 0.01; *** p < 0.001).
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Figure 3. Functional activity of LPLA2 deficient macrophages.
(A) Mycobacterium tuberculosis was incubated in Ringer solution of pH
5.0 or 7.5, respectively, containing different concentrations of recombi-
nant mouse LPLA2. At the indicated time points,M. tuberculosis viability
was determined by CFU analysis. Relative survival of M. tuberculosis is
shown as mean + SEM (n = 6) of data pooled from two independent
experiments. (B–D) Resting or IFN-γ (2000 U/mL O/N) activated peri-
toneal macrophages were infected with M. tuberculosis H37Rv at a MOI
of 1:1. (B) At the indicated time points, serial dilutions were plated onto
Middlebrook 7H11 agar plates for CFU determination. Data are shown
as mean + SEM from technical replicates (n = 3) and are representative
of two independent experiments. (C) NO2− production was determined
24 h after infection as described in the “Materials andmethods” section.
Data are shown as mean + SEM representing replicates (n = 6) pooled
from two independent experiments. (D) TNF-α production by LPLA2
KO peritoneal macrophages relative to WT peritoneal macrophages
24 h afterM. tuberculosis infection was calculated and pooled from three
independent experiments. Statistical analysis was performed using the
Student’s t-test (***p < 0.001).
proportions and numbers of both CD4+ and CD8+ T cells in
infected LPLA2 KO lungs when compared with WT ones (Fig. 4B).
More importantly, recall responses of CD4+ and CD8+ T cells
recruited to lungs of LPLA2 KO mice upon M. tuberculosis infec-
tion were severely impaired as revealed by limited secretion of
IFN-γ or TNF-α upon ex vivo restimulation with anti-CD3/CD28
or PPD. Twenty days after infection, WT lungs contained more
IFN-γ or TNF-α producing CD4+ and CD8+ T cells in response to
anti-CD3/CD28 stimulation ex vivo when compared with LPLA2
KO ones (Fig. 4C–E). Furthermore, a significant proportion of
lung-derived CD4+ T cells from WT mice responded to PPD by
IFN-γ−production. In contrast, infected LPLA2 KO lungs did not
contain PPD-specific IFN-γ−producing T cells (Fig. 4F). Notably,
this response was not simply delayed since it was still suppressed
49 days after infection (Fig. 4G). Impairment of pulmonary T-cell
responses in LPLA2 deficient mice uponM. tuberculosis infection is
not due to general incapability to activate T cells as proliferation of
ovalbumin specific T cells (OT1, OT2) upon antigen-injection was
unaffected by LPLA2 deficiency in infected as well as noninfected
mice (Supporting Information Fig. 3, data not shown).
Taken together, LPLA2 deficiency impaired pulmonary T-cell
responses uponM. tuberculosis infection including recruitment and
activation of antigen-specific CD4+ T cells.
Reduced Th1 cytokine responses to M. tuberculosis
infection in LPLA2 KO mice
In order to identify immune differences in LPLA2 KO versus WT
lungs, we analyzed the levels of MCP-1, IFN-γ, TNF-α, IL-10, IL-17,
NO, and of the small lipid mediators PGE2, LTB4,and LXA4 upon
M. tuberculosis infection. No differences were observed regarding
tissue levels of these immune mediators between WT and LPLA2
KO mice within the first 2 weeks of infection. However, on day
20 p.i., significantly higher levels of MCP-1 and TNF-α were mea-
sured in both lungs and spleens of WT when compared with LPLA2
KO mice (Fig. 5A and B). Although only statistically significant in
the spleen, IFN-γ was also reduced in lungs of LPLA2 KO compared
with WT. In line with decreased production of the proinflamma-
tory cytokines INF-γ and TNF-α, measurement of NO2− in sera
of infected mice revealed significantly reduced concentrations of
NO2− in LPLA2 KO compared with WT sera (Supporting Infor-
mation Fig. 1A). Levels of IL-10, which counterregulates proin-
flammatory immune responses, and IL-17A did not differ in the
infected lungs, but IL-10 was significantly higher in spleens of
LPLA2 KO mice 20 days p.i. (Supporting Information Fig. 1B and
C). This difference was only transient and no longer apparent 43
days after M. tuberculosis infection. Since nonlysosomal PLA2 are
involved in eicosanoid and proinflammatory lipid mediator pro-
duction, we also tested the amount of PGE2, LTB4, and LXA4 in
infected WT and LPLA2 KO mice. We did not observe differences
in the levels of these mediators in lung and mediastinal lymph
nodes but an increase in LTB4 and LXA4 levels in spleens of LPLA2
KO mice (Supporting Information Fig. 2).
Taken together, these data suggest that LPLA2 deficiency
results in diminished Th1 responses during experimental
M. tuberculosis infection.
LPLA2 deficiency results in impaired T-cell priming
in mLNs
To determine whether the reduced T-cell response in the lungs
of LPLA2 KO mice was associated with impaired T-cell priming
in mLNs, we analyzed the numbers of IFN-γ and TNF-α produc-
ing CD4+ and CD8+ T cells by ex vivo restimulation with anti-
CD3/CD28. Upon M. tuberculosis infection, mLNs from LPLA2 KO
mice were smaller in size, as reflected in a significant lower total
cell count (Fig. 6A) and significantly reduced CD4+ and CD8+
T-cell numbers compared with mLNs from WT mice (Fig. 6A). On
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
2398 Bianca E. Schneider et al. Eur. J. Immunol. 2014. 44: 2394–2404
Figure 4. T-cell responses to Mycobac-
terium tuberculosis in lungs of LPLA2
deficient mice. LPLA2 KO and WT B6
mice were infected by aerosol with
M. tuberculosis H37Rv ((A–E) 250 CFU;
(F and G) 150 CFU)). (A) 13 and 20 days
p.i. lungs were analyzed for the presence
of CD11bhiLy6G+ cells. (B) 20 days p.i.
lungs were analyzed for the presence of
CD4+ and CD8+ T cells by flow cytometry.
(C–E) 20 days after infection, whole lung
lysates were restimulated ex vivo with
anti-CD3/CD28 (5 μg/mL, respectively) and
analyzed by flow cytometry for the
presence of IFN-γ or TNF-α pro-
ducing CD4+ and CD8+ T cells.
(C) Representative dot plots of
cytokine-producing CD4+ and CD8+
T cells gated for CD44. (D and E) The
frequencies and numbers of gated
cytokine-producing CD4+ and CD8+ T cells
are shown. (F and G) 20 or 49 days after
infection, lung cells were restimulated ex
vivo with PPD (5 μg/mL) or left unstimu-
lated and analyzed by flow cytometry for
the presence of IFN-γ or TNF-α producing
CD4+ T cells gated for CD90.2. (A–G)
Data are shown as means + SD ((A–E)
n = 5; (F and G) n = 4) and represent
two independent experiments. Statistical
analysis was performed by Student’s t-test
(*p < 0.05; **p < 0.01; *** p < 0.001). For
full gating strategies, see Supporting
Information Fig. 4.
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Figure 5. Th1 cytokine responses to Mycobacterium tuberculosis infection in LPLA2 KO mice. Cytokine levels were measured in lung (A) and
spleen lysates (B) of LPLA2 KO and B6 WT mice on day 13, 20, and 43 post M. tuberculosis H37Rv aerosol infection (d1 CFU 250) by CBA as
described in the Materials and methods. Symbols and bars represent individual mice and means, respectively, and data from one experiment
representative of two experiments are shown. Statistical analysis was performed by ANOVA and Tukey’s Multiple Comparison test (*p < 0.05;
**p < 0.01; ***p < 0.001).
day 20 upon M. tuberculosis infection, mLNs from LPLA2 KO mice
contained significantly lower numbers of CD4+ and CD8+ T cells
that responded to anti-CD3/CD28 stimulation with IFN-γ or TNF-α
production (Fig. 6B–D) demonstrating defective priming of CD4+
and CD8+ T cells in the draining lymph nodes in the absence of
LPLA2.
Impaired TNF-α and CCL5 production in LPLA2 KO
mLNs upon M. tuberculosis infection
The kinetics of the T-cell response during M. tuberculosis infec-
tion is dependent on the transport of antigen from the lung to
the draining LNs in order to initiate T-cell priming. To ascertain
whether impaired T-cell priming was due to defective delivery
of M. tuberculosis to the mLNs, we analyzed mycobacterial loads
in mLNs at different time points over the first 3 weeks of infec-
tion. To our surprise, we did not detect differences in mLN CFU
at any of the time points analyzed (Fig. 6E). However, when we
compared mycobacterial loads in mLNs and lungs, the proportion
ofM. tuberculosis,whichwas delivered to themLNs, was decreased
in LPLA2 KO mice when compared with WT mice (Fig. 6F and G).
Despite this difference, it is unlikely that the reduced transport
of mycobacteria to mLNs in LPLA2 KO mice was responsible for
impaired T-cell priming since in WT mLNs, the amount of antigen
was also sufficient for T-cell priming.
In order to identify mechanisms other than antigen deliv-
ery, which could affect T-cell priming in the mLNs, we ana-
lyzed the production of a number of relevant chemokines and
cytokines. Among those tested, significantly lower amounts of
TNF-α and CCL5 were measured in LPLA2 KO mLNs (Fig. 6H
and I).
Taken together, production of TNF-α and CCL5was impaired in
LPLA2 KO mLNs upon M. tuberculosis infection, whereas transport
of M. tuberculosis to the mLNs was not affected.
Discussion
Macrophage effector functions are critical for the control of
mycobacterial infection and the initiation of an adaptive immune
response. LPLA2 is primarily expressed in tissue macrophages such
as alveolar and peritoneal ones and contributes to membrane
homeostasis and phospholipid turnover including surfactant
degradation [6]. LPLA2 deficiency leads to lysosomal accumula-
tion of phospholipids [6], mainly PE and PC, which results in the
formation of lamellar inclusion bodies, a hallmark of cellular phos-
pholipidosis. So far, the consequences of LPLA2 deficiency in infec-
tion and immunity have not been addressed. Here we show that
LPLA2 deficiency impairs establishment of protective pulmonary
Th1 immune responses to M. tuberculosis in vivo. Impaired adap-
tive immunity upon M. tuberculosis infection was characterized by
defective T-cell priming in the draining LNs and deficient CD4+
and CD8+ T-cell recruitment to infected lungs. Moreover, the
few recruited pulmonary T cells were unable to produce IFN-γ
or TNF-α upon ex vivo restimulation with anti-CD3/CD28. More
importantly, antigen-specific pulmonary T cells were not capable
of responding to PPD by IFN-γ secretion, suggesting that the pul-
monary LPLA2 deficient environment failed to promote activation
of mycobacteria-specific CD4+ T cells.
Reduced Th1 immune responses were associated with higher
bacterial loads in LPLA2 KO mice. A direct bactericidal effect
of the enzyme can most probably be ruled out by the fact
that (i) the viability of M. tuberculosis was not affected by
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Figure 6. T-cell priming and cytokine produc-
tion in mediastinal lymph nodes. LPLA2 KO
and WT B6 mice were infected by aerosol with
Mycobacterium tuberculosis H37Rv (d1 CFU 250).
(A) 20 days p.i. mediastinal lymphnodes (mLNs)
were analyzed for absolute cell numbers and
the presence of CD4+ and CD8+ T cells by flow
cytometry. (B–D) MLN lysates were prepared
on day 20 p.i., restimulated ex vivo with anti-
CD3/CD28 (5μg/mL, respectively), and analyzed
by flow cytometry for the presence of IFN-γ
or TNF-α producing CD4+ and CD8+ T cells.
(B) Representative dot plots of cytokine-
producing CD4+ and CD8+ T cells gated for
CD44 from one mouse out of five analyzed are
shown. (C and D) The frequencies and numbers
of gated cytokine-producing CD4+ and CD8+
T cells are shown as means + SD (n = 5). (A–
D) Data are shown as means + SD and repre-
sent one experiment with five mice per group.
Statistical analysis was performed by Student’s
t-test (*p < 0.05; **p < 0.01). (E and F) Mice were
sacrificed after the indicated time points upon
aerosol infection and serial dilutions of mLN
and lung lysates were plated for CFU determi-
nation. Symbols and bars represent individual
mice and means, respectively, and data pooled
from two independent experiments are shown.
(G) The ratio of M. tuberculosis CFU in mLNs
relative to the lungs is given as means + SD
(n = 5–8). (H and I) Levels of TNF-α and
CCL5 were determined in mLN lysates by
CBA as described in the “Materials and
methods” section. Symbols and bars rep-
resent individual mice and means, respec-
tively, and represent one experiment with
eight–ten mice per group. Statistical anal-
ysis was performed by Student’s t-test
(*p < 0.05; **p < 0.01; ***p < 0.001). For full gating
strategies, see Supporting Information Figure 4.
in vitro treatment with recombinant LPLA2, (ii) pathogenic
M. tuberculosis survived and replicated equally well in both
WT and LPLA2 KO macrophages, and (iii) tissue macrophages,
when preactivated with IFN-γ, restricted mycobacterial growth
equally well in the presence or absence of LPLA2. These find-
ings indicate that in vivo LPLA2 KO macrophages are insuffi-
ciently activated or macrophages recruitment is limited in the
absence of LPLA2, or both. In fact, we observed lower numbers
of CD11bhiLy6G+ inflammatory monocytes infiltrating the lung
tissue of LPLA2 KO mice upon M. tuberculosis infection than that
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of WT mice. The failure to recruit inflammatory monocytes to the
site of infection most likely affects control of M. tuberculosis and
thereby promotes bacterial growth as observed in the absence of
LPLA2.
Another reason for the failure of LPLA2 KO mice to control
M. tuberculosis is most probably reduced production of the
proinflammatory cytokine TNF-α. Macrophages and T cells
are the primary TNF-α sources in tuberculosis. For both,
we have shown impaired TNF-α production in the absence
of LPLA2. IL-10, a cytokine counterregulating inflammatory
Th1 responses, was only enhanced in LPLA2 KO mouse
spleens at day 20 p.i. but otherwise comparable between
KO and WT mice and is therefore not likely to dampen
proinflammatory immune responses in the absence of LPLA2
during the whole course of infection. We can also rule out a regu-
latory role for IL-17A that was not affected by lack of LPLA2. The
same applies for PGE2 synthesis, a bioactive lipid mediator known
to inhibit macrophages functions on T-cell activation [10–13]. To
date, no role for LPLA2 has been observed in arachidonic acid
release and prostanoid formation and according to our own data
PGE2, LTB4, and LXA4 production is not impaired inM. tuberculosis
infected mice in the absence of LPLA2.
Impaired degradation of lipid membranes may affect presenta-
tion of both bacterial lipid and protein antigens. Only recently,
Paduraru and colleagues described a role for LPLA2 in iNKT
cell-mediated CD1d recognition [14]. In other murine lysosomal
storage disease models, the numbers of CD1d-restricted iNKT cells
are often diminished, irrespective of the glycolipid species accumu-
lated or the glycolipid catalytic/synthetic pathway genes affected
[15]. In our hands, however, LPLA2 deficient APCs were not defec-
tive in their ability to stimulate both CD1d-dependent autoreactive
as well as αGalCer reactive NKT-cell clones (data not shown). In
contrast to NKT cells, which have limited immune function in
murine tuberculosis, conventional Th1 CD4+ T cells are essen-
tial for controlling M. tuberculosis in mice [16, 17]. Our data
demonstrate that impaired recruitment of CD4+ T cells and Th1
responses render LPLA2 KO mice more susceptible to infection by
M. tuberculosis. Importantly, recruitment and activation of CD8+
T cells are also hampered in the absence of LPLA2. It should,
however, be noted that T-cell activation was not generally
impaired as ovalbumin specific CD4+ and CD8+ T cells prolifer-
ated normally in WT and LPLA2 KO lungs upon adoptive transfer
and subsequent antigen injection.
Failed recruitment of immune cells is most probably due to
defective production of chemokines at the site of infection. In fact,
levels of MCP-1 (CCL2), which is chemotactic for macrophages,
DCs, NK cells, and T cells, were significantly lower in lungs and
spleens of M. tuberculosis infected LPLA2 KO mice than WT mice.
Hence, decreased production of MCP-1 could at least in part
explain reduced inflammation and subsequent impaired recruit-
ment of IFN-γ producing T cells in infected LPLA2 KO lungs. Mice
lacking CCL2 display a similar phenotype regarding decreased pul-
monary recruitment of macrophages upon aerosol infection with
M. tuberculosis. However, these mice show similar numbers of
activated T cells and only a transient reduction in the number of
IFN-γ secreting T cells [18]. Accordingly, these mice only show a
transient increase in mycobacterial loads. In contrast, mycobacte-
rial loads in the lungs of LPLA2 KO mice still exceed that in lungs
of WT mice by 1 log after several months of infection. Further-
more, dissemination ofM. tuberculosis to the spleen is not affected
in CCL2 KO mice. Therefore, decreased levels of MCP-1 alone
cannot account for the observed phenotype of M. tuberculosis
infected LPLA2 KO mice. Production of TNF-α was also affected by
LPLA2 deficiency. TNF-α does not only participate in macrophages
activation but promotes recruitment of immune cells to the site
of infection by upregulation of endothelial adhesion molecules
[19] and chemokine production [20, 21]. Hence, insufficient pro-
duction of TNF-α might further limit production of chemokines
involved in the recruitment of leukocytes to the site of infection. In
line with this, we found decreased levels of the chemokines KC and
MIP-1β early in M. tuberculosis in lungs of LPLA2 KO mice (data
not shown).
M. tuberculosis dissemination is a prerequisite for priming of
adaptive immunity [22]. Our data suggest that LPLA2 deficiency
impairs early dissemination of mycobacteria to the spleen but not
to the lung draining mLNs. However, while the absence of LPLA2
did not affect mycobacterial loads in the mLNs, it significantly
reduced the production of TNF-α and CCL5, both of which
contribute to early protection against M. tuberculosis infection
[23, 24]. As activated macrophages are the main TNF-α produc-
ers, diminished production of this cytokine indicates that LPLA2
deficient macrophages are not fully activated in vivo. Although
DCs are regarded the predominant APC population responsible
for T-cell priming in the draining LN during M. tuberculosis
infection [8], defective macrophages activation can still limit acti-
vation and maintenance of T-cell responses. Like TNF-α, CCL5 is
produced by a wide variety of cells including macrophages in
response to M. tuberculosis infection [25]. In addition to its
chemotactic property attracting a number of immune cells includ-
ing T cells and macrophages, CCL5 directly contributes to T-cell
activation [26–28]. Thus, significantly abated CCL5 production
in mLNs is likely to preclude T-cell priming and proliferation in
LPLA2 KO mice.
The fact that LPLA2 KO mice, despite having higher bac-
terial loads, succumb to infection earlier than WT mice but
only at very late time points, even upon a high initial dose of
M. tuberculosis, indicates that the limited T-cell activation observed
is still sufficient to keep the infection at bay for long time. It is,
however, important to note that inflammatory responses were
less pronounced in tissues of LPLA2 KO in comparison to
WT mice, resulting in milder pathological sequelae, which is
beneficial for the host as long as immune control restricts
mycobacterial replication to some extend at the same time
[29].
In conclusion, our study demonstrates that LPLA2 is involved in
protective host immunity to tuberculosis. Deficiency of LPLA2 com-
promises macrophages functions in vivo leading to both impaired
innate and adaptive immunity to M. tuberculosis. These results
identify an unexpected and novel functional principle of this lyso-
somal phospholipid-degrading enzyme.
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Materials and methods
Bacterial strains and culture
M. tuberculosis H37Rv was grown in Middlebrook 7H9 broth (BD
Biosciences) supplemented with 0.5% glycerol and Tween 80,
and OADC (Oleic acid, Albumin, Dextrose, Catalase) enrichment
medium (BD). Bacterial cultures were harvested and aliquots were
frozen at −80°C until later use. Viable cell counts in thawed
aliquots were determined by plating serial dilutions onto Mid-
dlebrook 7H11 agar plates followed by incubation at 37°C for
4 weeks.
Mice, infection, and colony forming units
C57BL/6 and LPLA2 KO mice were bred and housed under spe-
cific pathogen-free (SPF) conditions at the Biological Service
Facility of the London School of Hygiene and Tropical Medicine
(London, UK) or the Research Center Borstel (Germany). LPLA2
KO mice were generated by targeted disruption of the lpla2 gene
in a clean C57BL/6 N background as described [6]. In any given
experiment, mice were matched for age and sex and used at
the age of 12 weeks and older, because at that age, the phos-
pholipidosis phenotype of LPLA2 KO mice becomes more evident
[6]. For infection experiments, mice were maintained under spe-
cific barrier conditions in BSL 3 facilities. All animal experiments
were performed in accordance with the Animals (Scientific Pro-
cedures) Act 1986 or German Animal Protection Law and were
approved by the London School of Hygiene and Tropical Medicine
Ethical Review Committee or the Ethics Committee for Animal
Experiments of the Ministry for Agriculture, Environment, and
Rural Areas of the State of Schleswig-Holstein, Germany (Kommis-
sion fu¨r Tierversuche/Ethik-Kommission des Landes Schleswig-
Holstein) under the license 102–8/09 (“Die Bedeutung der lyso-
somalen Phospholipase A2 (LPLA2) fu¨r die Immunantwort gegen
den Tuberkuloseerreger in derMaus”/“The role of lysosomal phos-
pholipase A2 (LPLA2) for immune response to the causative agent
of tuberculosis in the mouse model”).
For infection of experimental animals, M. tuberculosis stocks
were diluted in sterile distilled water/1% v/v Tween-80/1%
w/v albumin. Infection was performed via the respiratory route
by using an aerosol chamber (Glas-Col, Terre-Haute, IN, USA).
Animals were exposed for 60 min to an aerosol generated by
nebulising the prepared M. tuberculosis suspension. The inocu-
lum size was verified by sacrificing mice 24 h after infection and
determining the bacterial load in the lungs of infected mice. For
each experiment, the exact day 1 CFU is indicated in the figure
legend.
Bacterial load in lung, mLNs, and spleen was evaluated at
different time points after aerosol infection by mechanical dis-
ruption of the organs in 0.05% v/v Tween 20 in PBS contain-
ing a proteinase inhibitor cocktail (Roche Diagnostics) prepared
according to the manufacturer’s instructions. Tenfold serial dilu-
tions of organ homogenates in sterile water/1% v/v Tween 80/1%
w/v albumin were plated onto Middlebrook 7H11 agar plates
and incubated at 37°C. Colonies were counted after 4 weeks of
culture.
Macrophage isolation and infection
To collect resident peritoneal macrophages, peritoneal cavities
of naive mice were lavaged with cold PBS (calcium and mag-
nesium free) containing 0.5 mM EDTA. Peritoneal macrophages
were suspended in RPMI 1640 medium containing 10% fetal calf
serum, 5% Glutamine, 1% HEPES, and 50 mM β-mercaptoethanol
and plated into 96-well plates at 2 × 105 cells per well for
CFU analysis. Nonadherent cells were removed by washing with
PBS.
To determine the intracellular survival of M. tuberculosis
H37Rv in WT and LPLA2-deficient macrophages, resting or IFN-γ
(2000 U/mL O/N) activated peritoneal macrophages were
infected with M. tuberculosis H37Rv at a MOI of 1:1 for 2 h.
Extracellular bacteria were removed by washing with PBS, and
cells were further incubated or lysed with 0.5% v/v Triton X-100
in H2O at the indicated times. Serial dilutions were plated onto
Middlebrook 7H11 agar plates followed by incubation at 37°C.
In vitro activity of recombinant LPLA2 on M.
tuberculosis
M. tuberculosis was incubated in Ringer solution of pH 5.0 or 7.5,
respectively, containing 1 μg/mL recombinant mouse LPLA2 [30].
After 30 and 120 min, M. tuberculosis viability was determined
by plating serial dilutions onto Middlebrook 7H11 agar plates
followed by incubation at 37°C for 4 weeks.
Multiplex cytokine assays
The concentrations of CCL5, MCP-1, IFN-γ, TNF-α, and IL-10
were determined in mLNs, lung, or spleen homogenates from
uninfected and infected mice by cytometric bead array (BD Bio-
sciences) according to the manufacturer’s protocol. For detection
of IL-17A, the enhanced sensitivity beads (BD) were used, which
can detect cytokine concentrations down to 0.274 pg/mL.
Nitric oxide assay
Nitric oxide was determined in sera from infected mice or in cell
culture supernatants from infected macrophages as NO2− follow-
ing reduction of NO3, using the Griess-reaction described previ-
ously [31].
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Small lipid mediator detection
The concentration of PGE2, LTB4, or LXA4 was determined
in mLNs, lung and spleen homogenates from WT and LPLA2
KO mice by The Parameter PGE2 or LTB4 Immunoassays
(R&D Systems), or the Lipoxin A4 BioAssay ELISA Kit (United
States Biological), respectively, according to the manufacturer’s
protocols.
Histology
Organs fromM. tuberculosis-infected mice were fixed with 4%w/v
PFA in PBS for 24 h and embedded in paraffin. Sections (3 μm)
were rehydrated by running through xylenes, alcohols of decreas-
ing concentrations, and finally water. Sections were stained with
hematoxylin and eosin (H&E). Mycobacteria in lungs were visual-
ized by acid-fast staining (TB Stain Kit K, BD Biosciences) accord-
ing to manufacturer’s protocol.
Cell isolation from lung, spleen, and mLNs
Lungs were removed, sectioned, and incubated in PBS contain-
ing liberase (1.5 mg/mL; Worthington Biochemical) and DNAse I
(250 μg/mL; Worthington Biochemical) at 37°C for 90 min.
Digested lung tissue was broken into single-cell suspension by sub-
sequent passage through a 100 μm pore size nylon cell strainer.
MLNs and spleens were also passed through a 100 μm pore size
nylon cell strainer to obtain single-cell suspensions. Remaining
erythrocytes were lysed and cells were resuspended in RPMI 1640
medium supplemented with 2 mM glutamine, 1% Hepes (v/v),
β-mercaptoethanol (50 μM), and 10% (v/v) heat-inactivated fetal
calf serum (complete RPMI 1640 medium).
Flow cytometry
In order to analyze surface expression of CD90.2, CD4, CD8,
CD11b, and Ly6G, single-cell suspensions were incubated with flu-
orescently labelled antibodies (BD Biosciences) for 30 min at 4°C
and subsequently analyzed by flow cytometry on a FacsCantoII R©
flow cytometer (BD Biosciences) equipped with a 405 nm, 488
nm, and 633 nm laser and the FCSExpress software (DeNovoTM
Software).
Ex vivo T-cell restimulation
Lung or mLN cells (1× 106) was stimulated for 5 h with a puri-
fied protein derivative (PPD) of M. tuberculosis (5 μg/mL) or
anti-CD3 and anti-CD28 (5 μg/mL, respectively) in the pres-
ence of GolgiPlug (BD Biosciences, contains brefeldin A). Sub-
sequently, cells were stained with anti-CD90.2, anti-CD44, anti-
CD4, and anti-CD8 antibodies (BioLegend) for 20min at 4°C. After
washing, cells were incubated for 20 min with Cytofix/Cytoperm
(BD Biosciences). Cells were washed with Perm/Wash buffer (BD
Biosciences), and stained with anti-IFN-γ (XMG1.2) and anti-
TNF-α (MP6-XT22) antibodies for 45 min at 4°C. Cells were ana-
lyzed using a BD FACSCanto flow cytometer (BD Biosciences) and
FCSExpress software.
Adoptive transfer of ovalbumin specific T cells
CD4+ or CD8+ T cells were isolated from spleens of OT2 or OT1
mice, respectively, by negative selection via magnetic activated
cell sorting and labelled with CFSE (Invitrogen) at a final con-
centration of 5 μM. CFSE-labelled T cells (1 × 107 OT1 and
1 × 107 OT2 cells) were adoptively transferred into B6 or LPLA2
mice, which had been infected withM. tuberculosis 20 days before.
One day after adoptive transfer, 250 μg Ovalbumin in PBS or PBS
alone were injected intraperitoneally. After 3 days, lungs were har-
vested and single-cell suspensions were stained for CD90.2, CD4,
and CD8 and analyzed for proliferation of CFSE+ T cells using a
BD FACSCanto flow cytometer (BD Biosciences) and FCSExpress
software.
Statistical analysis
The unpaired Student’s t-test was employed to compare bacterial
titres, cell numbers, organ weight, T-cell frequencies and cytokine
levels, and the log-rank test to compare the survival of mice after
M. tuberculosis infection.
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